Overall Technical outlook

Price Summary

On 2025-10-16, Ajanta Pharma Limited's stock opened at 2424.9, reached a high of 2511.0, dropped to a low of 2409.8, and closed up 1.37% at 2458.2, with a trading volume of 85339 shares.
During the 52-week span, the stock hit a high of 3199.55 and a low of 2374.45.
The projected price range for Ajanta Pharma Limited is between 2307.0 and 3293.0, with an expected mean price of 3023.077, according to 13 analysts.

Technicals

Support and Resistance: The price of 2458.2 is supported at 2392.0 and encounters resistance at 2575.7. This suggests key levels where the price might find stability, with 2392.0 providing a base and 2575.7 acting as an upper boundary for AJANTPHARM.
AJANTPHARM supportResistance 2a5cf2
Support/Resistance for AJANTPHARM


Aroon: A strong bullish trend is currently being indicated by the AROON. The Aroon Up has moved higher, and the Aroon Oscillator has reversed, signaling a shift to an upward trend. This suggests that the market may be entering a period of increased bullish activity, with investors likely to see further price increases in the price of Ajanta Pharma Limited in the near future.
AJANTPHARM aroon 2a5cf2
Aroon chart for Ajanta Pharma Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Ajanta Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
AJANTPHARM bbands 2a5cf2
Bolinger Bands chart for Ajanta Pharma Limited


Parabolic SAR: The PSAR has just reversed direction from bearish to bullish, suggesting a possible trend change. If this shift is supported by other indicators, it could indicate a strong bullish trend. Investors should monitor this development closely, seeking confirmation from other market signals before acting.
AJANTPHARM psar 2a5cf2
Parabolic Stop and Reverse chart for Ajanta Pharma Limited


Stochastic: The STOCHASTIC is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
AJANTPHARM stoch 2a5cf2
Stochastic chart for Ajanta Pharma Limited


Tripple Moving Agerage: The 20-50-100 period moving averages suggest a bullish trend, but the slopes of the faster averages indicate that this strength may be weakening. The potential for a reversal is becoming apparent, as the shorter-term averages show signs of fading momentum, suggesting that a trend change could be imminent.
AJANTPHARM trippleSMA 2a5cf2
Tripple SMA chart for Ajanta Pharma Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.